Bruns Ingmar (CIK 0001838041)

Latest company ownership

ZNTL - Zentalis Pharmaceuticals, Inc.
Role: Chief Medical Officer
Shares held
36,629
Last filed at
Feb 12, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 6, 2025 Feb 12, 2025 Zentalis Pharmaceuticals, Inc. Chief Medical Officer Buy 91.3 +20,000 120.27% ✗ $45.7K